# Hangzhou Tigermed Consulting Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-tigermed-consulting-company

- Industry: Healthcare
- Headquarters: Hangzhou, China
- Website: www.tigermed.net
- Total disclosed funding: $5M
- Latest round: Series A (Jul 10, 2008)
- Investors on record: 1

## About

Founded in 2004 and based in Hangzhou, China, Hangzhou Tigermed Consulting Company Limited operates as a contract research organization that provides enterprises with regulatory processing, clinical research, biometrics, and medical translation services. The company has set up more than 100 subsidiaries. The co-founder as well as the CEO of the company, Xiaoping Ye, worked at Squibb Pharmaceuticals. Tigermed has over 10,000 employees and 29 overseas branches in Singapore, Malaysia, Indonesia, UK, Canada and other countries. In August 2020, the company was listed on Hong Kong Stock Exchange.

Tigermed provides a full range of services including Phase I-IV clinical trials, registration, data management and statistical analysis, and medical translation. The services offered by the company can be used in all types of pharmaceutical products, including drugs, medical devices, diagnostic reagents and health food and can be used in therapeutic areas of hepatitis and oncology.

The company will further improve the delivery and service systems and will recruit the CRO personnel.

## Funding rounds

- Series A, Jul 10, 2008, $5M — Qiming Venture Partners

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A